Singapore vs Switzerland: Proportion of the target population who received the final dose of
Singapore
70.0%
in 2024
Switzerland
70.0%
in 2024
Singapore rank
44th
Switzerland rank
44th
Proportion of the target population who received the final dose of over time
- Singapore
- Switzerland
How they compare
Singapore currently reports 70.0% against 70.0% in Switzerland, a difference of 0.0%.
The two have swapped places 2 times across 13 shared years of data; in 2012 it was Switzerland ahead.
Singapore ranks 44th and Switzerland ranks 44th of 107 countries.
Across the 2 decades both report, Singapore averaged higher in 1 and Switzerland in 1.
Head to head by decade
| Decade | Singapore | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 11.4% | 55.9% | 44.5% | Switzerland |
| 2020s | 74.6% | 69.0% | 5.6% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Singapore or Switzerland?
- Singapore, at 70.0% against 70.0% in Switzerland as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Singapore and Switzerland?
- 0.0%, with Singapore ahead.
- How many years of comparable data are there for Singapore and Switzerland?
- 13 years are reported by both, from 2012 to 2024.
- How do Singapore and Switzerland rank globally for proportion of the target population who received the final dose of?
- Singapore ranks 44th and Switzerland ranks 44th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.